Transient upregulation of PGC-1alpha diminishes cardiac ischemia tolerance via upregulation of ANT1.
about
Erythropoietin: new directions for the nervous systemCardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor γ coactivator 1α/estrogen related receptor axis.PGC-1α attenuates hydrogen peroxide-induced apoptotic cell death by upregulating Nrf-2 via GSK3β inactivation mediated by activated p38 in HK-2 Cells.Mitochondrial Fe-S cluster biogenesis, frataxin and the modulation of susceptibility to drug-induced cardiomyopathy.Promoting PGC-1α-driven mitochondrial biogenesis is detrimental in pressure-overloaded mouse hearts.Targeting cardiovascular disease with novel SIRT1 pathways.PGC-1α limits angiotensin II-induced rat vascular smooth muscle cells proliferation via attenuating NOX1-mediated generation of reactive oxygen speciesIschemic postconditioning protects the heart against ischemia-reperfusion injury via neuronal nitric oxide synthase in the sarcoplasmic reticulum and mitochondriaImpaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart.Modulation of apoptosis by sulforaphane is associated with PGC-1α stimulation and decreased oxidative stress in cardiac myoblasts.Increasing the level of peroxisome proliferator-activated receptor γ coactivator-1α in podocytes results in collapsing glomerulopathy.Mitochondria and PGC-1α in Aging and Age-Associated Diseases.Expression of adenine nucleotide translocase (ANT) isoform genes is controlled by PGC-1α through different transcription factors.Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice.PGC1α in the kidney.ATP-ADP translocase and effects on ischemic heart.
P2860
Q26828425-1AB1F0BE-C210-4D48-A573-031FF8DE384EQ30426226-8C36D684-7783-42F7-BD5B-8DD7828F680DQ33849235-F64C8CC0-B2A1-4BF9-9A6D-B3F6670F681AQ34424872-1D2C0AB8-52FA-4A78-94A1-5CF84FE14EA7Q34439944-179361B0-3444-49C0-B76A-2AE38D9665E6Q35661632-E939EFC9-8D58-44F3-8DE7-95B516E09B57Q36185160-F18465E7-ACC7-4559-AA36-B1AB5F2E88E6Q37030270-6F275A4D-B6FC-4F39-BA3F-80D97F866B01Q38317335-04FD9F0B-B5D2-4350-B7A8-EB9EBE08F276Q38931697-88720CD9-F621-4283-AC0B-FE9098B6D6DEQ41068117-AF727CA6-D6D4-4271-9306-AE6CFA39EC51Q42738266-DA922CF1-732C-49FB-975E-5A72D92B7913Q42802869-CE1E3183-257C-478F-BB60-7D2441224C60Q47350464-B2634FC7-A458-4D71-93C7-5771B3762093Q47938445-D9B3C4A1-3859-450F-B384-C17D248B7464Q52853538-1A4AFB12-219F-4CB2-8C00-4AFEB195553A
P2860
Transient upregulation of PGC-1alpha diminishes cardiac ischemia tolerance via upregulation of ANT1.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Transient upregulation of PGC- ...... ance via upregulation of ANT1.
@ast
Transient upregulation of PGC- ...... ance via upregulation of ANT1.
@en
Transient upregulation of PGC- ...... ance via upregulation of ANT1.
@nl
type
label
Transient upregulation of PGC- ...... ance via upregulation of ANT1.
@ast
Transient upregulation of PGC- ...... ance via upregulation of ANT1.
@en
Transient upregulation of PGC- ...... ance via upregulation of ANT1.
@nl
prefLabel
Transient upregulation of PGC- ...... ance via upregulation of ANT1.
@ast
Transient upregulation of PGC- ...... ance via upregulation of ANT1.
@en
Transient upregulation of PGC- ...... ance via upregulation of ANT1.
@nl
P2093
P2860
P1476
Transient upregulation of PGC- ...... rance via upregulation of ANT1
@en
P2093
Darin Carabenciov
Elizabeth Murphy
Jeremy Jacobson
Mark V Stevens
Michael N Sack
Renee P Wong
P2860
P304
P356
10.1016/J.YJMCC.2010.06.008
P577
2010-07-01T00:00:00Z